Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28149247 | 0.72 | ALDH1A1 (0.35) | GAAALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL8342783 | 0.72 | ALDH1A1 (0.35) | GAAALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL8635961 | 0.69 | SMN1; SMN2 (0.33) | GAAALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL1046284 | 0.65 | SMN1; SMN2 (0.38) | ALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL30702419 | 0.65 | SMN1; SMN2 (0.38) | ALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL9004674 | 0.65 | VDR (0.38) | GAAALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL28250648 | 0.65 | ALDH1A1 (0.38) | GAAALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL26858967 | 0.65 | PPARG (0.36) | ALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL378842 | 0.64 | GSK3B (0.38) | GAAALDH1A1SMN1; SMN2BCHE | |
| SCHEMBL29366806 | 0.64 | GSK3B (0.38) | GAAALDH1A1SMN1; SMN2BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576242-B2 | N-Ethylpyridinium bis(pentafluoroethyl)phosphinate; reacting tris(perfluoroalkyl)phosphine oxide is reacted with an alcohol and an organic base; ionic liquids | MERCK PATENT GMBH (DE) | 2009-08-18 | — | — | US | disclosed |
| US-20070128515-A1 | Process for the preparation of organic salts containing bis(perfluoroalkyl) phosphinate anions | MERCK PATENT GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070128515-A1 | Process for the preparation of organic salts containing bis(perfluoroalkyl) phosphinate anions | PHOSPHO1, PFAS, PFKFB1 | GAA 4751/4885ALDH1A1 1861/4885SMN1; SMN2 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.